IL78017A - Sustained release tablets of theophylline - Google Patents
Sustained release tablets of theophyllineInfo
- Publication number
- IL78017A IL78017A IL78017A IL7801786A IL78017A IL 78017 A IL78017 A IL 78017A IL 78017 A IL78017 A IL 78017A IL 7801786 A IL7801786 A IL 7801786A IL 78017 A IL78017 A IL 78017A
- Authority
- IL
- Israel
- Prior art keywords
- theophylline
- sustained release
- release tablets
- relates
- tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL78017A IL78017A (en) | 1986-03-03 | 1986-03-03 | Sustained release tablets of theophylline |
CA000522807A CA1276107C (en) | 1986-03-03 | 1986-11-12 | Sustained release tablets of theophylline |
JP61270831A JPH06104625B2 (ja) | 1986-03-03 | 1986-11-13 | 徐放性錠剤 |
AT86115815T ATE59960T1 (de) | 1986-03-03 | 1986-11-14 | Theophyllintabletten mit verzoegerter freigabe. |
DE8686115815T DE3676997D1 (de) | 1986-03-03 | 1986-11-14 | Theophyllintabletten mit verzoegerter freigabe. |
EP86115815A EP0235363B1 (de) | 1986-03-03 | 1986-11-14 | Theophyllintabletten mit verzögerter Freigabe |
US06/938,265 US4795645A (en) | 1986-03-03 | 1986-11-25 | Sustained release tablets of theophylline |
ZA876498A ZA876498B (en) | 1986-03-03 | 1987-08-31 | Sustained release tablets of theophylline |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL78017A IL78017A (en) | 1986-03-03 | 1986-03-03 | Sustained release tablets of theophylline |
Publications (2)
Publication Number | Publication Date |
---|---|
IL78017A0 IL78017A0 (en) | 1986-07-31 |
IL78017A true IL78017A (en) | 1989-06-30 |
Family
ID=11056558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL78017A IL78017A (en) | 1986-03-03 | 1986-03-03 | Sustained release tablets of theophylline |
Country Status (7)
Country | Link |
---|---|
US (1) | US4795645A (de) |
EP (1) | EP0235363B1 (de) |
JP (1) | JPH06104625B2 (de) |
AT (1) | ATE59960T1 (de) |
CA (1) | CA1276107C (de) |
DE (1) | DE3676997D1 (de) |
IL (1) | IL78017A (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988006457A1 (en) * | 1987-03-04 | 1988-09-07 | Nippon Hypox Laboratories Incorporated | Medicinal composition containing albumin as carrier and process for its preparation |
US5023080A (en) * | 1988-06-17 | 1991-06-11 | Basic Bio Systems, Inc. | Time release protein |
FR2650502B1 (fr) * | 1989-08-07 | 1994-05-27 | Delagrange Laboratoires | Nouvelle forme galenique orale ameliorant la biodisponibilite |
GB2284761A (en) * | 1993-12-03 | 1995-06-21 | Euro Celtique Sa | Prophylactic treatment of asthma |
DE19739031A1 (de) * | 1997-09-05 | 1999-03-11 | Suwelack Nachf Dr Otto | Mittel zur peroralen Verabreichung, seine Herstellung und Verwendung |
MY121142A (en) * | 1999-02-23 | 2005-12-30 | Smithkline Beecham Corp | Controlled release formulation for treating copd |
US6602911B2 (en) * | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
AU2003225837B2 (en) * | 2002-03-15 | 2008-11-06 | Forest Laboratories Holdings Limited | NE and 5-HT reuptake inhibitors for treating visceral pain syndromes |
US20040121010A1 (en) * | 2002-10-25 | 2004-06-24 | Collegium Pharmaceutical, Inc. | Pulsatile release compositions of milnacipran |
US20060003004A1 (en) * | 2002-10-25 | 2006-01-05 | Collegium Pharmaceutical, Inc. | Pulsatile release compositions of milnacipran |
AU2004207578B2 (en) * | 2003-01-28 | 2007-06-28 | Collegium Pharmaceutical, Inc. | Multiparticulate compositions of milnacipran for oral administration |
US7994220B2 (en) * | 2005-09-28 | 2011-08-09 | Cypress Bioscience, Inc. | Milnacipran for the long-term treatment of fibromyalgia syndrome |
US20110268666A1 (en) * | 2008-09-29 | 2011-11-03 | Yissum Research Development Company of the Research University of Jerusalem, Ltd. | Novel gastroretentive delivery system |
US20130040982A1 (en) * | 2010-04-22 | 2013-02-14 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Oral sustained release formulation of huperzine a |
CN116966157B (zh) * | 2023-09-22 | 2024-02-09 | 山东则正医药技术有限公司 | 一种茶碱缓释片及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL297088A (de) * | 1961-01-31 | |||
US3922379A (en) * | 1973-12-17 | 1975-11-25 | Abbott Lab | Microencapsulation process |
US4002756A (en) * | 1974-04-22 | 1977-01-11 | Interx Research Corporation | Useful pro-drug forms of theophylline |
US4147167A (en) * | 1976-08-05 | 1979-04-03 | Horst R. Hickmann | Ophthalmic prosthesis implant instrument |
US4223031A (en) * | 1978-05-05 | 1980-09-16 | Mead Johnson & Company | Azolopyrimidinones |
JPS55153715A (en) * | 1979-05-18 | 1980-11-29 | Nikken Kagaku Kk | Prolonged granule of theophylline |
DE3104815C2 (de) * | 1980-02-13 | 1983-07-07 | Japan Atomic Energy Research Institute, Tokyo | Verfahren zur Herstellung eines Verbundstoffs mit Langzeit-Freigabe |
JPS6042205B2 (ja) * | 1980-12-22 | 1985-09-20 | 日本原子力研究所 | 徐放性複合体の製造方法 |
US4465660A (en) * | 1981-04-01 | 1984-08-14 | Mead Johnson & Company | Sustained release tablet containing at least 95 percent theophylline |
ZA836031B (en) * | 1983-08-16 | 1985-02-27 | Verex Lab | Constant release rate solid dosage theophylline formulation |
US4695591A (en) * | 1985-03-29 | 1987-09-22 | Schering Corporation | Controlled release dosage forms comprising hydroxypropylmethylcellulose |
US4710384A (en) * | 1986-07-28 | 1987-12-01 | Avner Rotman | Sustained release tablets made from microcapsules |
-
1986
- 1986-03-03 IL IL78017A patent/IL78017A/xx unknown
- 1986-11-12 CA CA000522807A patent/CA1276107C/en not_active Expired - Lifetime
- 1986-11-13 JP JP61270831A patent/JPH06104625B2/ja not_active Expired - Lifetime
- 1986-11-14 EP EP86115815A patent/EP0235363B1/de not_active Expired - Lifetime
- 1986-11-14 DE DE8686115815T patent/DE3676997D1/de not_active Expired - Lifetime
- 1986-11-14 AT AT86115815T patent/ATE59960T1/de not_active IP Right Cessation
- 1986-11-25 US US06/938,265 patent/US4795645A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH06104625B2 (ja) | 1994-12-21 |
JPS62207217A (ja) | 1987-09-11 |
ATE59960T1 (de) | 1991-02-15 |
CA1276107C (en) | 1990-11-13 |
EP0235363A3 (en) | 1987-11-19 |
US4795645A (en) | 1989-01-03 |
EP0235363B1 (de) | 1991-01-16 |
DE3676997D1 (de) | 1991-02-21 |
EP0235363A2 (de) | 1987-09-09 |
IL78017A0 (en) | 1986-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL78017A (en) | Sustained release tablets of theophylline | |
CS410191A3 (en) | Benzimidazoles, process of their preparation and medicaments comprising said compounds | |
PT84359A (en) | Process for the preparation of granules containing an active substance and to the use thereof as speckles for treating substrates | |
HUT41642A (en) | Process for producing tablets of regulated dissolution of the active agents | |
HUT54491A (en) | Quickly soluble pharmaceutical unit dosage and process for producing same | |
HU895334D0 (en) | Process for the preparation of nasal pharmaceutical compositions | |
AU552547B2 (en) | Nonapeptide for treatment of drug withdrawal symptoms | |
DE2960292D1 (en) | 17-beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes, their pharmaceutical use and processes for their preparation | |
ZA871657B (en) | Process for the preparation of medicament adsorbates | |
HUT48269A (en) | Process for producing pharmaceutically active nukleozide and pharmaceutical compositions containing them | |
PT84899A (en) | Process for the preparation of pharmaceutical compositions containing ?-phenyl-1,2-benzisoselenazol-3(2h)-one for the treatment of skin diseases | |
HUT49494A (en) | Process for producing active component of pharmaceutical compositions | |
DE3062981D1 (en) | Alkyl-urea derivatives for the treatment of lipometabolic diseases; process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives | |
HUT46930A (en) | Process for producing aminoglycoside-steroides and pharmaceutical compositions containing them as active components | |
ES8607916A1 (es) | Un procedimiento para la preparacion de medicamentos influenciadores de la circulacion sanguinea, que contienen compuestos de bis (carboxamida) | |
JPS5572117A (en) | Analgesic tablet and its manufacture | |
HUT46837A (en) | Compositions of insectifuge and acarifuge activity containing alpha, omega-amino-alkohol derivatives as active components and process for producing the active components | |
HUT52958A (en) | Process for production of medical compositions assuring the constant release of the active substance | |
ZA837332B (en) | Novel galenic form of sulpiride,process for its preparation and medicament comprising said novel form | |
ES8502701A1 (es) | Procedimiento para preparar derivados de xantina | |
HUT49807A (en) | Process for production of medical compositions and the active substance | |
EP0270682A4 (de) | Neue komplexe deren herstellung und verwendung als arzneimittel. | |
ZA812362B (en) | Monohydrated isophthalic acid picolylamide, process of preparation and pharmaceutical use thereof | |
PT85602A (en) | Oxolabdanes a process for their preparation and their use as medicaments | |
ZA802391B (en) | Medicinal preparation for treating carcinomas and process of producing the preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed |